Investors — Monobind

Investor Information

Building Long-Term Value in Diagnostic Science

Monobind is a privately held, U.S.-based diagnostic manufacturer developing immunoassays, laboratory technologies, reagents, and specialized biomaterials for customers around the world.

Contact Investor Relations Learn About Monobind

Company Overview

An Established Private Diagnostics Company

Founded in 1977 by Dr. Rick Jerome, Monobind has grown from its early work in radioimmunoassay into an integrated diagnostic manufacturer with capabilities spanning immunoassay development, reagent production, laboratory instrumentation, biomaterials, quality systems, and global distribution.

The company remains privately held and focused on sustainable growth, scientific innovation, operational capability, and long-term value creation.

Investment Perspective

Positioned Across Multiple Diagnostic Markets

Monobind participates in complementary areas of the in vitro diagnostics industry, including clinical immunoassays, automated laboratory platforms, diagnostic raw materials, specialty matrices, OEM manufacturing, and international distribution.

This diversified capability base allows the company to support laboratories, distributors, researchers, and diagnostic manufacturers through multiple product and partnership models.

Company Strengths

A Platform Built for Long-Term Growth

Monobind combines scientific expertise, established manufacturing, international reach, and a broad portfolio of diagnostic technologies.

01

Established Operating History

More than four decades of experience in diagnostic science, product development, manufacturing, and international markets.

02

Integrated Capabilities

In-house scientific, production, quality, biomaterial, automation, packaging, and commercial capabilities support greater control and responsiveness.

03

Diversified Portfolio

Products and services span clinical assays, instrumentation, diagnostic biomaterials, specialty matrices, OEM programs, and research applications.

04

Global Market Reach

An established international distributor and customer network supports participation across diverse geographic markets.

Business Platform

Multiple Paths to Market

Monobind serves the diagnostic industry through complementary products, technologies, and commercial relationships.

Strategic Relationships

More Than Financial Investment

Monobind welcomes appropriate discussions with organizations and individuals whose experience, market access, technologies, or resources may complement the company’s long-term strategy.

Potential areas of alignment may include strategic investment, technology collaboration, product development, manufacturing, distribution, licensing, or other mutually beneficial relationships.

Scientific Leadership

Founded and Guided by Diagnostic Expertise

Monobind was founded by Dr. Frederick “Rick” Jerome, who holds a PhD in Organic Chemistry and continues to serve as Founder and Chief Scientific Officer. His leadership has helped guide the company’s development across immunoassay science, reagent systems, diagnostic manufacturing, and biomaterials.

In 2024, Dr. Jerome received the Distinguished Alumnus Award from the USC Department of Chemistry in recognition of his outstanding contributions to the medical technology industry.

Read the Award Announcement

Investor Inquiries

Start a Confidential Conversation

Qualified parties interested in discussing potential investment or strategic opportunities may contact Monobind directly. Please include your name, organization, area of interest, and relevant background.

Important Notice

Monobind Inc. is a privately held company. Information on this page is provided for general informational purposes only and does not constitute an offer to sell, a solicitation of an offer to purchase, or investment, legal, tax, or financial advice. Any potential transaction would be subject to appropriate review, documentation, eligibility requirements, and applicable laws.